Novonesis AS (Novonesis AS) Other Long-Term Liabilities : $325 Mil (As of Dec. 2023)

View and export this data going back to 2009. Start your Free Trial

What is Novonesis AS Other Long-Term Liabilities?

Novonesis AS's other long-term liabilities for the quarter that ended in Dec. 2023 was $325 Mil.

Novonesis AS's quarterly other long-term liabilities declined from Jun. 2023 ($1,065 Mil) to Sep. 2023 ($1,026 Mil) and declined from Sep. 2023 ($1,026 Mil) to Dec. 2023 ($325 Mil).

Novonesis AS's annual other long-term liabilities declined from Dec. 2021 ($992 Mil) to Dec. 2022 ($411 Mil) and declined from Dec. 2022 ($411 Mil) to Dec. 2023 ($325 Mil).

Novonesis AS Other Long-Term Liabilities Historical Data

The historical data trend for Novonesis AS's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novonesis AS Other Long-Term Liabilities Chart

Novonesis AS Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Long-Term Liabilities

Get a 7-Day Free Trial

Novonesis AS Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Other Long-Term Liabilities	Get a 7-Day Free Trial															-	-	-	-	-

Novonesis AS Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Novonesis AS Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Novonesis AS's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Novonesis AS (Novonesis AS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Novonesis AS (OTCPK:NVZMY) » Definitions » Other Long-Term Liabilities

Comparable Companies

Traded in Other Exchanges

NVZMF:USA NZYM:Mexico NZYMBc:UK 0Q4U:UK NZYM B:Denmark NZM2:Germany

Address

Krogshoejvej 36, Bagsvaerd, DNK, 2880

Website

https://www.novozymes.com

Novozymes is the world leader in industrial enzymes. In recent years, the company has expanded into micro-organisms, primarily for agricultural markets. The firm supplies five major industry groups: household care, food and beverages, bioenergy, agriculture and feed, and technical and pharma. Its biological solutions create value for its customers by improving yield efficiency and performance, while saving energy and generating less waste. The company is headquartered in Denmark.

Novonesis AS (Novonesis AS) Headlines

From GuruFocus

2 Holdings to Reduce Based on Analyst Recommendations

By Alberto Abaterusso Alberto Abaterusso • 11-06-2019

Not Just Yogurt Anymore

By PRNewswire • 10-26-2023

Novozymes A/S's Dividend Analysis

By GuruFocus Research • 10-19-2023

Novozymes Named EPA Safer Choice Partner of the Year for Third Year in a Row

By PRNewswire • 10-03-2023